Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 21;7(3):ofaa102.
doi: 10.1093/ofid/ofaa102. eCollection 2020 Mar.

High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019

Wei Cao  1 , Xiaosheng Liu  2 , Tao Bai  3 , Hongwei Fan  1 , Ke Hong  3 , Hui Song  3 , Yang Han  1 , Ling Lin  1 , Lianguo Ruan  3 , Taisheng Li  1
Affiliations

High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019

Wei Cao et al. Open Forum Infect Dis. .

Abstract

The outbreak of coronavirus disease 2019 (COVID-19) has spread rapidly in China. Until now, no definite effective treatment has been identified. We reported on 3 patients with severe COVID-19 who received high-dose intravenous immunoglobulin (IVIg) with satisfactory recovery. Based on these observations, randomized studies of high-dose IVIg should be considered in deteriorating patients infected with COVID-19.

Keywords: coronavirus disease 2019; high-dose intravenous immunoglobulin; immunomodulation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Chest computed tomography scan of patient 1 (A), patient 2 (B), and patient 3 (C) before and after high-dose intravenous immunoglobulin with days of illness.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Real-time updates: national outbreak map of new coronary virus pneumonia Available at: https://news.sina.cn/zt_d/yiqing0121. Accessed 12 March 2020.
    1. National Health Commission of the People’s Republic of China. Chinese recommendations for diagnosis and treatment of novel coronavirus (SARS-CoV2) infection (pilot 4th version). Available at: http://www.gov.cn/zhengce/zhengceku/2020-01/28/5472673/files/0f96c10cc09.... Accessed 12 March 2020.
    1. Huang C, Wang Y, Li X, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395:497–506. - PMC - PubMed
    1. Zhu N, Zhang D, Wang W, et al. . A novel coronavirus from patients with pneumonia in China, 2019. New Engl J Med 2020; 382:727–33. - PMC - PubMed
    1. Chung M, Bernheim A, Mei X, et al. . CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology 2020; 295:202–07. - PMC - PubMed